Evidence map›Paper›PMID 28821231›Full record

ArticleBMC medical genetics2017

Novel mutations in PANK2 and PLA2G6 genes in patients with neurodegenerative disorders: two case reports.

Hassan Dastsooz, Hamid Nemati, Mohammad Ali Farazi Fard, Majid Fardaei, Mohammad Ali Faghihi

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. A rare inherited homozygous missense variant inTranslational pediatrics · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Hassan DastsoozComprehensive Medical Genetic Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hamid NematiShiraz Neuroscience Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. nematih@sums.ac.ir.
Mohammad Ali Farazi FardDepartment of Medical Genetics, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Majid FardaeiComprehensive Medical Genetic Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Mohammad Ali FaghihiCenter for Therapeutic Innovation and Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, USA. MFaghihi@med.miami.edu.
Shiraz University of Medical Sciences · IRUniversity of Miami · US

Funding

Antisense RNA Mediated Epigenetic Regulation of Brain Derived Neurotrophic FactorR01NS081208 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FAGHIHI, MOHAMMAD ALI · 2013 to 2017
$1.7M
NINDS NIH HHS R01 NS081208
6 · The paper itself

Abstract

backgroundNeurodegeneration with brain iron accumulation (NBIA) is a genetically heterogeneous group of disorders associated with progressive impairment of movement, vision, and cognition. The disease is initially diagnosed on the basis of changes in brain magnetic resonance imaging which indicate an abnormal brain iron accumulation in the basal ganglia. However, the diagnosis of specific types should be based on both clinical findings and molecular genetic testing for genes associated with different types of NBIA, including PANK2, PLA2G6, C19orf12, FA2H, ATP13A2, WDR45, COASY, FTL, CP, and DCAF17. The purpose of this study was to investigate disease-causing mutations in two patients with distinct NBIA disorders. CASE PRESENTATION: Whole Exome sequencing using Next Generation Illumina Sequencing was used to enrich all exons of protein-coding genes as well as some other important genomic regions in these two affected patients. A deleterious homozygous four-nucleotide deletion causing frameshift deletion in PANK2 gene (c.1426_1429delATGA, p.M476 fs) was identified in an 8 years old girl with dystonia, bone fracture, muscle rigidity, abnormal movement, lack of coordination and chorea. In addition, our study revealed a novel missense mutation in PLA2G6 gene (c.3G > T:p.M1I) in one and half-year-old boy with muscle weakness and neurodevelopmental regression (speech, motor and cognition). The novel mutations were also confirmed by Sanger sequencing in the proband and their parents.

conclusionsCurrent study uncovered two rare novel mutations in PANK2 and PLA2G6 genes in patients with NBIA disorder and such studies may help to conduct genetic counseling and prenatal diagnosis more accurately for individuals at the high risk of these types of disorders.

Indexed as

Amino Acid SequenceBrainChildDNA Mutational AnalysisDyskinesiasDystoniaExonsFemaleFrameshift MutationGene DeletionGene Regulatory NetworksGroup VI Phospholipases A2High-Throughput Nucleotide SequencingHumansInfantMaleGroup VI Phospholipases A2pantothenate kinasePhosphotransferases (Alcohol Group Acceptor)PLA2G6 protein, humanCase reportNBIAPANK2PKANPLA2G6

Identifiers

PMID28821231
PMCPMC5562981
OpenAlexW2746524013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.